Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by cool888on Jun 02, 2021 3:47pm
131 Views
Post# 33312553

China Reports First Possible Human Case of H10N3 Bird Flu !

China Reports First Possible Human Case of H10N3 Bird Flu !





China Reports First Possible Human Case of H10N3 Bird Flu

 Updated on 

Beijing (AP) -- A man in eastern China has contracted what might be the world’s first human case of the H10N3 strain of bird flu, but the risk of large-scale spread is low, the government said Tuesday.

 
 

The 41-year-old man in Jiangsu province, northwest of Shanghai, was hospitalized April 28 and is in stable condition, the National Health Commission said on its website.

 
 

No human case of H10N3 has been reported elsewhere, the commission said.

 
 

“This infection is an accidental cross-species transmission,” its statement said. “The risk of large-scale transmission is low.”
 

The news comes amid heightened awareness of the threat of emerging diseases as the COVID-19 pandemic continues to claim lives around the world.

But unlike with coronaviruses, there are global influenza surveillance systems that watch for human cases of bird flu, since a strain named H5N1 cropped up in the late 1990s in Hong Kong’s crowded live-poultry markets.

Between 2013 and 2017, another bird flu named H7N9 infected more than 1,500 people in China through close contact with infected chickens.

With that history, authorities aren’t surprised to see occasional human cases of various bird flu strains and they monitor closely for any signs one is spreading between people.


<< Previous
Bullboard Posts
Next >>